{"schema_version":"secwatch.filing_event.v1","accession":"0000882835-22-000021","form_type":"8-K","ticker":"ROP","cik":"0000882835","company_name":"ROPER TECHNOLOGIES INC","filed_at":"2022-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.098685+00:00","generated_at":"2026-06-26T04:53:07.773429+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Roper Q1 adj DEPS $3.77 (+10%), revenue +11%; raises FY 2022 guidance to $15.50-$15.75","bullets":["Q1 GAAP DEPS $2.70 (+6%); adjusted DEPS $3.77 (+10%) on revenue of $1.53B (+11% organic).","Adjusted EBITDA $577M (37.8% margin); operating cash flow $474M, free cash flow $459M.","Full-year 2022 adjusted DEPS guidance raised to $15.50-$15.75 (prior $15.25-$15.55); Q2 guided $3.80-$3.84.","Completed divestitures of TransCore, Zetec, and CIVCO Radiotherapy; cash proceeds to fund acquisition pipeline."],"urls":{"canonical":"https://secwatch.observer/filing/0000882835-22-000021","json":"https://secwatch.observer/filing/0000882835-22-000021.json","markdown":"https://secwatch.observer/filing/0000882835-22-000021.md","text":"https://secwatch.observer/filing/0000882835-22-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882835/000088283522000021/0000882835-22-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882835/000088283522000021/rop-20220426.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T04:53:07.773429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}